Hemophilia B (factor IXSeattle 2) due to a single nucleotide deletion in the gene for factor IX.

To understand the molecular basis for hemophilia B in patients with little or no circulating Factor IX antigen, a patient who had less than 0.2% circulating Factor IX antigen (Factor IXSeattle 2) was selected for analysis of his Factor IX gene. Genomic DNA fragments from the abnormal gene were clone...

Ausführliche Beschreibung

Bibliografische Detailangaben

Veröffentlicht in:	J Clin Invest
Hauptverfasser:	Schach, B G, Yoshitake, S, Davie, E W
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	American Society for Clinical Investigation 1987
Schlagworte:	Research Article
Online-Zugang:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC442341/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/2821070/ https://ncbi.nlm.nih.govhttps://doi.org/10.1172/JCI113155
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!